Commentary on Markiewicz et al. Age-related changes in patients with upper limb thalidomide embryopathy in the United Kingdom

Ghassemi Jahani SA Karlsson J Brisby H Danielsson AJ. Health-related quality of life and function in middle-aged individuals with thalidomide embryopathy. J Child Orthop. 2016, 10: 691–703.

Hinoshita F Beppu H Shioji S , et al. A nationwide survey regarding the life situations of patients with thalidomide embryopathy in Japan, 2018: first report. Birth Defects Res. 2019, 111: 1633–42.

Kowalski TW Sanseverino MT Schuler-Faccini L Vianna FS. Thalidomide embryopathy: follow-up of cases born between 1959 and 2010. Birth Defects Res A Clin Mol Teratol. 2015, 103: 794–803.

Markiewicz M Stirling P Brennan S Hooper G Lam W. Age-related changes in patients with upper limb thalidomide embryopathy in the United Kingdom. J Hand Surg Eur. Epub ahead of print 6 April 2023. DOI: 10.1177/17531934231164093.

Nicotra A Newman C Johnson M , et al. Peripheral nerve dysfunction in middle-aged subjects born with thalidomide embryopathy. PLoS One. 2016, 11: e0152902.

Niecke A Peters KM Alayli A , et al. Health-related quality of life after 50 years in individuals with thalidomide embryopathy: evidence from a German cross-sectional survey. Birth Defects Res. 2022, 114: 714–24.

Oshima Y Okutsu I Hamanaka I Motomura T. Carpal tunnel syndrome accompanying radial dysplasia due to thalidomide embryopathy. J Hand Surg Br. 2006, 31: 342–4.

Therapontos C Erskine L Gardner ER Figg WD Vargesson N. Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation. Proc Natl Acad Sci USA. 2009, 106: 8573–8.